Skip to content

Layla Elsokari

NPI 1508420225ActiveIndividual· Nurse Practitioner, Pediatrics· New York, NY

Nurse Practitioner, Pediatrics in New York, New York, licensed in NY, with an NPI issued in April 2019. Part D covered 17 prescriptions written in 2024, 82% of them generic. Otsuka Pharmaceutical Development & Commercialization, Inc. was the largest of 2 companies reporting payments in 2025, $57.07 in all, mostly food and beverage.

Overview

NPI1508420225
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 29, 2019
Last updated in NPPESApr 29, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Nurse Practitioner, Pediatrics Primary363LP0200X382960NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)17 · 23 30-day fills
Total drug cost$1,126
Generic share82% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$57.07 · 3 payments from 2 companies
  • 2024$25.45 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$57.07 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pediatric nurse practitioners in New York

All 437 pediatric nurse practitioners in New York · All pediatric nurse practitioners in New York